Skip to main content
. 2012 Jun 5;7(6):e38242. doi: 10.1371/journal.pone.0038242

Figure 4. Clearing assays with AmB (a), flucytosine (b), allicin (c), AmB + allicin (d), flucytosine + allicin (e), and AmB + flucytosine + allicin (f).

Figure 4

Spot number 1 indicates the control sample. The spots numbered 2, 3, and 4 correspond to antifungal treatments with the concentrations of MIC10×10−1, MIC10, and MIC90, respectively.